You just read:

Grünenthal and Mesoblast Enter Strategic Partnership for Europe and Latin America to Develop and Commercialise Innovative Cell Therapy for the Treatment of Chronic Low Back Pain

News provided by

Grünenthal Group

10 Sep, 2019, 16:24 BST